Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-03-03 @ 8:19 AM
Study NCT ID:
NCT04608305
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2020-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine
Sponsor:
Israel Institute for Biological Research (IIBR)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-26
First Submit QC Date:
None
Study First Post Date:
2020-10-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-15
Last Update Post Date:
2023-11-18
Last Update Post Date Type:
ACTUAL